Sanofi SA vs SoFi Technologies Inc — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while SoFi Technologies Inc trades at $17.63 (market cap $21.82B). The key difference: Sanofi SA is far larger — about 4.8× SoFi Technologies Inc's market cap, and Sanofi SA pays a 5.5% dividend while SoFi Technologies Inc pays none. Which is the better fit depends on your goals.
| SNY | SOFI | |
|---|---|---|
Market Cap | $104.83B | $21.82B |
Sector | Health | Financials |
52-Week High | $52.34 | $32.21 |
52-Week Low | $41.33 | $15.15 |
Enterprise Value | $121.32B | — |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →